Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-20 | ARDELYX, INC. | Williams Laura A
(Chief Medical Officer) |
S | Common Stock | D | 7366 | $4.79 - $4.79 | $35,316 |
| 2024-11-20 | ARDELYX, INC. | Rosenbaum David P.
(Chief Development Officer) |
S | Common Stock | D | 7184 | $4.79 - $4.79 | $34,443 |
| 2024-11-20 | ARDELYX, INC. | Renz Justin A
(Chief Financial Officer) |
S | Common Stock | D | 5260 | $4.79 - $4.79 | $25,219 |
| 2024-11-20 | ARDELYX, INC. | RAAB MICHAEL
(President & CEO) |
S | Common Stock | D | 31980 | $4.79 - $4.79 | $153,328 |
| 2024-11-20 | ARDELYX, INC. | GRAMMER ELIZABETH A
(See Remarks) |
S | Common Stock | D | 7046 | $4.79 - $4.79 | $33,782 |
| 2024-11-20 | ARDELYX, INC. | Blanks Robert
(See Remarks) |
S | Common Stock | D | 4941 | $4.79 - $4.79 | $23,689 |
| 2024-11-06 | ARDELYX, INC. | Rosenbaum David P.
(Chief Development Officer) |
S | Common Stock | D | 27171 | $6.10 - $6.10 | $165,743 |
| 2024-11-06 | ARDELYX, INC. | Rosenbaum David P.
(Chief Development Officer) |
M | Common Stock | A | 27171 | $2.32 - $2.32 | $63,036 |
| 2024-11-04 | ARDELYX, INC. | Rosenbaum David P.
(Chief Development Officer) |
S | Common Stock | D | 27172 | $5.95 - $5.95 | $161,673 |
| 2024-11-04 | ARDELYX, INC. | Rosenbaum David P.
(Chief Development Officer) |
M | Common Stock | A | 27172 | $2.32 - $2.32 | $63,039 |
| 2024-10-28 | ARDELYX, INC. | RAAB MICHAEL
(President & CEO) |
S | Common Stock | D | 25000 | $5.91 - $5.91 | $147,740 |
| 2024-10-28 | ARDELYX, INC. | RAAB MICHAEL
(President & CEO) |
M | Common Stock | A | 25000 | $0.99 - $0.99 | $24,750 |
| 2024-10-11 | ARDELYX, INC. | RAAB MICHAEL
(President & CEO) |
S | Common Stock | D | 7500 | $6.01 - $6.01 | $45,075 |
| 2024-09-13 | ARDELYX, INC. | Rosenbaum David P.
(Chief Development Officer) |
S | Common Stock | D | 5312 | $6.26 - $6.26 | $33,253 |
| 2024-09-11 | ARDELYX, INC. | RAAB MICHAEL
(President & CEO) |
S | Common Stock | D | 35000 | $5.61 - $5.61 | $196,399 |
| 2024-09-11 | ARDELYX, INC. | RAAB MICHAEL
(President & CEO) |
M | Common Stock | A | 35000 | $0.99 - $0.99 | $34,650 |
| 2024-08-27 | ARDELYX, INC. | RAAB MICHAEL
(President & CEO) |
S | Common Stock | D | 7500 | $6.22 - $6.22 | $46,635 |
| 2024-08-20 | ARDELYX, INC. | Williams Laura A
(Chief Medical Officer) |
S | Common Stock | D | 7412 | $5.86 - $5.86 | $43,436 |
| 2024-08-20 | ARDELYX, INC. | Rosenbaum David P.
(Chief Development Officer) |
S | Common Stock | D | 7219 | $5.86 - $5.86 | $42,304 |
| 2024-08-20 | ARDELYX, INC. | Renz Justin A
(Chief Financial Officer) |
S | Common Stock | D | 5289 | $5.86 - $5.86 | $30,995 |
| 2024-08-20 | ARDELYX, INC. | RAAB MICHAEL
(President & CEO) |
S | Common Stock | D | 32225 | $5.86 - $5.86 | $188,848 |
| 2024-08-20 | ARDELYX, INC. | GRAMMER ELIZABETH A
(See Remarks) |
S | Common Stock | D | 7089 | $5.86 - $5.86 | $41,543 |
| 2024-08-20 | ARDELYX, INC. | Felsch Robert Ora
(See Remarks) |
S | Common Stock | D | 3567 | $5.86 - $5.86 | $20,903 |
| 2024-08-20 | ARDELYX, INC. | Blanks Robert
(See Remarks) |
S | Common Stock | D | 4969 | $5.86 - $5.86 | $29,119 |
| 2024-08-16 | ARDELYX, INC. | Rosenbaum David P.
(Chief Development Officer) |
S | Common Stock | D | 40507 | $5.94 - $6.00 | $241,782 |
| 2024-08-20 | ARDELYX, INC. | Rosenbaum David P.
(Chief Development Officer) |
M | Common Stock | A | 20507 | $0.99 - $0.99 | $20,301 |
| 2024-08-08 | ARDELYX, INC. | Foster Eric Duane
(Chief Commercial Officer) |
A | Common Stock | A | 180000 | $0.00 - $0.00 | $0 |
| 2024-08-12 | ARDELYX, INC. | RAAB MICHAEL
(President & CEO) |
S | Common Stock | D | 1229 | $5.71 - $5.71 | $7,017 |
| 2024-07-29 | ARDELYX, INC. | RAAB MICHAEL
(President & CEO) |
S | Common Stock | D | 30000 | $5.64 - $5.64 | $169,314 |
| 2024-07-29 | ARDELYX, INC. | RAAB MICHAEL
(President & CEO) |
M | Common Stock | A | 30000 | $0.99 - $0.99 | $29,700 |
| 2024-07-15 | ARDELYX, INC. | RAAB MICHAEL
(President & CEO) |
S | Common Stock | D | 7500 | $5.97 - $5.97 | $44,767 |
| 2024-06-28 | ARDELYX, INC. | RAAB MICHAEL
(President & CEO) |
S | Common Stock | D | 2310 | $6.59 - $6.59 | $15,222 |
| 2024-06-21 | ARDELYX, INC. | Blanks Robert
(See Remarks) |
S | Common Stock | D | 38000 | $5.96 - $5.96 | $226,290 |
| 2024-06-14 | ARDELYX, INC. | Rodgers Richard J
(Director) |
A | Common Stock | A | 12204 | $0.00 - $0.00 | $0 |
| 2024-06-14 | ARDELYX, INC. | Bertrand William ...
(Director) |
A | Common Stock | A | 11023 | $0.00 - $0.00 | $0 |
| 2024-06-14 | ARDELYX, INC. | MOTT DAVID M
(Director) |
A | Common Stock | A | 17322 | $0.00 - $0.00 | $0 |
| 2024-06-13 | ARDELYX, INC. | RAAB MICHAEL
(President & CEO) |
S | Common Stock | D | 35000 | $6.65 - $6.65 | $232,743 |
| 2024-06-13 | ARDELYX, INC. | RAAB MICHAEL
(President & CEO) |
M | Common Stock | A | 35000 | $0.99 - $0.99 | $34,650 |
| 2024-06-05 | ARDELYX, INC. | Williams Laura A
(Chief Medical Officer) |
S | Common Stock | D | 145000 | $7.12 - $7.12 | $1,033,080 |
| 2024-06-05 | ARDELYX, INC. | Williams Laura A
(Chief Medical Officer) |
M | Common Stock | A | 100000 | $2.75 - $2.75 | $275,000 |
| 2024-06-03 | ARDELYX, INC. | Rosenbaum David P.
(Chief Development Officer) |
S | Common Stock | D | 17872 | $7.00 - $7.00 | $125,104 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |